会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • SYSTEM AND METHOD FOR PROVIDING CELL SPECIFIC LASER THERAPY OF ATHEROSCLEROTIC PLAQUES BY TARGETING LIGHT ABSORBERS IN MACROPHAGES
    • 用于通过将光吸收剂靶向在宏观物体中提供细胞特异性激光治疗动脉粥样硬化斑块的系统和方法
    • WO2007103721A3
    • 2007-11-08
    • PCT/US2007063058
    • 2007-03-01
    • GEN HOSPITAL CORPNADKARNI SEEMANTINI KTEARNEY GUILLERMO JBOUMA BRETT EVAKOC BENJAMIN JANDERSON RICHARD ROX
    • NADKARNI SEEMANTINI KTEARNEY GUILLERMO JBOUMA BRETT EVAKOC BENJAMIN JANDERSON RICHARD ROX
    • A61N5/06
    • A61B18/245A61N5/0601A61N5/062
    • An apparatus and method according to the present invention can be provided, e.g., for a cell specific laser therapy of atherosclerotic plaques, particularly to systems and methods for targeting endogenous light absorbers present within plaque macrophages and exogenous nanoparticle targeting. In one exemplary embodiment, an electro-magnetic radiation can be forwarded to an anatomical structure. The electro-magnetic radiation may have at least one property configured to (a) modify at least one characteristic of at least one first cell, and (b) minimize any modification of and/or modify at least one characteristic of at least second cell. The first and second cells may be different from one another, the characteristics of the first and second cells can be different from one another, and the first cell and/or the second cell may have at least one macrophage feature, and the characteristic of the at least one first cell and/or the at least one second cell can be temperature. According to still another exemplary embodiment, a location associated with the first cell and the second cell can be determined. For example, the electro-magnetic radiation can be forwarded in a vicinity of the location.
    • 可以提供根据本发明的设备和方法,例如用于动脉粥样硬化斑块的细胞特异性激光治疗,特别是用于靶向存在于斑块巨噬细胞内的内源光吸收剂和外源纳米颗粒靶向的系统和方法。 在一个示例性实施例中,电磁辐射可被转发至解剖结构。 电磁辐射可以具有至少一种性质,其被配置为(a)修改至少一个第一电池的至少一个特性,并且(b)最小化至少第二电池的任何修改和/或修改至少一个特性。 第一和第二细胞可以彼此不同,第一和第二细胞的特征可以彼此不同,并且第一细胞和/或第二细胞可以具有至少一个巨噬细胞特征,并且第一和第二细胞的特征 至少一个第一电池和/或至少一个第二电池可以是温度。 根据又一示例性实施例,可以确定与第一小区和第二小区相关联的位置。 例如,可以在该位置附近发送电磁辐射。
    • 9. 发明申请
    • METHODS AND APPARATUS FOR TREATMENT OF OCULAR MELANOSIS
    • 用于治疗眼球炎的方法和装置
    • WO2005096766A3
    • 2005-12-22
    • PCT/US2005011438
    • 2005-04-04
    • GEN HOSPITAL CORPANDERSON RICHARD ROXAKITA HIROTAKA
    • ANDERSON RICHARD ROXAKITA HIROTAKA
    • A61B18/20A61F9/009A61N5/067
    • A61F9/009A61B18/203A61B2018/00452A61F9/008A61F2009/00865
    • The invention entails a novel system and method for modifying scleral pigmentation. More particularly, the invention entails a novel system and method for treating Ocular Melanosis (OM). The invention contemplates a system and method for treating OM that uses lasers with modified pulse widths and low power to whiten the sclera without causing damage to the retina. Ultimately, a system has been developed that uses of low laser pulse fluences considerably less than those used for treating nevus of Ota on the skin. The system limits the risk of retinal injury by use of (a) a small exposure spot size and (b) a high numerical aperture (NA) optical beam with fluences of between about 0.5 J/cm and 5.0 J/Am , significantly lower than many currently available laser treatments. In a preferred embodiment, the system of the invention uses a laser with a wavelength in the visible and near-infrared spectrum and a pulse width from about 1 ns - 100 microseconds.
    • 本发明涉及一种用于改善巩膜色素沉着的新型系统和方法。 更具体地说,本发明需要一种治疗眼部黑色素瘤(OM)的新型系统和方法。 本发明考虑了一种用于治疗OM的系统和方法,其使用具有修改的脉冲宽度和低功率的激光来增加巩膜而不会对视网膜造成损害。 最终,已经开发了一种使用低激光脉冲通量的系统,其显着小于用于治疗皮肤上的Ota痣的那些。 该系统通过使用(a)小的曝光光斑尺寸和(b)具有约0.5J / cm 2和5.0J / Am 2之间的通量的高数值孔径(NA)光束来限制视网膜损伤的风险, 2>,显着低于许多目前可用的激光治疗。 在优选实施例中,本发明的系统使用具有可见光和近红外光谱波长的激光,脉冲宽度约为1ns-100微秒。